EPISODE · Dec 24, 2023 · 46 MIN
Health411 - Sickle Cell Gene Editing Therapy
from Health411 · host Dr. Jonathan Karp
In this episode of Health411, host Dr. Jonathan Karp and producers Daniel Geller and Josh Brewer delve into the groundbreaking world of Casgevy, the first FDA-approved CRISPR/Cas9-based treatment for sickle cell anemia. They explore the science behind this revolutionary gene-editing therapy, its potential implications for patients, and the ethical considerations surrounding genetic interventions in healthcare.
Embed this episode
NOW PLAYING
Health411 - Sickle Cell Gene Editing Therapy
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.